1.33
전일 마감가:
$1.34
열려 있는:
$1.34
하루 거래량:
59,626
Relative Volume:
0.13
시가총액:
$79.68M
수익:
$2.91M
순이익/손실:
$-220.40M
주가수익비율:
-0.3654
EPS:
-3.64
순현금흐름:
$-176.15M
1주 성능:
-3.26%
1개월 성능:
-15.51%
6개월 성능:
-86.61%
1년 성능:
-90.25%
Igm Biosciences Inc Stock (IGMS) Company Profile
명칭
Igm Biosciences Inc
전화
650-965-7873
주소
325 E MIDDLEFIELD ROAD, MOUNTAIN VIEW
IGMS을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
IGMS
Igm Biosciences Inc
|
1.325 | 79.68M | 2.91M | -220.40M | -176.15M | -3.64 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
476.99 | 121.85B | 11.02B | -535.60M | -978.00M | -2.20 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
697.93 | 76.83B | 14.20B | 4.41B | 3.54B | 38.28 |
![]()
ARGX
Argen X Se Adr
|
618.18 | 37.96B | 1.86B | -40.29M | -1.28B | -0.85 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
241.99 | 30.69B | 2.25B | -278.16M | -42.59M | -2.17 |
![]()
ONC
Beone Medicines Ltd Adr
|
269.08 | 29.71B | 3.32B | -860.46M | -1.04B | -8.32 |
Igm Biosciences Inc Stock (IGMS) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2025-01-10 | 다운그레이드 | BMO Capital Markets | Outperform → Market Perform |
2025-01-10 | 다운그레이드 | Guggenheim | Buy → Neutral |
2025-01-10 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
2025-01-10 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
2025-01-10 | 다운그레이드 | Stifel | Buy → Hold |
2024-12-06 | 개시 | BMO Capital Markets | Outperform |
2024-10-01 | 다운그레이드 | JP Morgan | Neutral → Underweight |
2024-10-01 | 다운그레이드 | Truist | Buy → Hold |
2024-02-09 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
2023-12-15 | 다운그레이드 | BofA Securities | Buy → Neutral |
2023-12-07 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
2022-11-09 | 재개 | Jefferies | Buy |
2022-10-17 | 개시 | JP Morgan | Neutral |
2022-08-29 | 개시 | BofA Securities | Buy |
2021-12-13 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
2021-11-05 | 업그레이드 | Wedbush | Neutral → Outperform |
2021-08-26 | 개시 | Morgan Stanley | Overweight |
2021-01-29 | 개시 | RBC Capital Mkts | Outperform |
2021-01-19 | 재확인 | H.C. Wainwright | Buy |
2020-12-22 | 다운그레이드 | Wedbush | Outperform → Neutral |
2020-07-17 | 개시 | Robert W. Baird | Outperform |
2020-07-01 | 개시 | H.C. Wainwright | Buy |
2020-05-28 | 개시 | SunTrust | Buy |
2020-04-22 | 개시 | Wedbush | Outperform |
2019-10-14 | 개시 | Guggenheim | Buy |
2019-10-14 | 개시 | Jefferies | Buy |
2019-10-14 | 개시 | Piper Jaffray | Overweight |
2019-10-14 | 개시 | Stifel | Buy |
모두보기
Igm Biosciences Inc 주식(IGMS)의 최신 뉴스
IGM Biosciences, Inc. (NASDAQ:IGMS) Receives Consensus Rating of “Reduce” from Brokerages - Defense World
IGM Biosciences, Inc. (IGMS) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release - Yahoo Finance
IGM Biosciences (IGMS) Projected to Post Quarterly Earnings on Thursday - Defense World
IGM to slash 73% of workforce, halt two drug programs - MSN
Fierce Biotech Layoff Tracker 2025: Encoded trims 29% of team; Inventiva halves staff - Fierce Biotech
Layoff Tracker: Viracta, X4 and BMS Detail Current, Upcoming Cuts - BioSpace
Brokerages Set IGM Biosciences, Inc. (NASDAQ:IGMS) PT at $5.50 - MarketBeat
IGM Biosciences, Inc. (NASDAQ:IGMS) Receives $5.50 Consensus Price Target from Analysts - Defense World
Down -76.91% in 4 Weeks, Here's Why IGM Biosciences (IGMS) Looks Ripe for a Turnaround - Nasdaq
Impressive Stock Surge: IGM Biosciences, XTI Aerospace and More See Major Gains – Market - HPBL
Impressive Stock Gains Across Multiple Sectors: IGM Biosciences, XTI Aerospace, and More Surge - HPBL
IGM Biosciences stock plunges to 52-week low of $1.59 - MSN
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of IGM Biosciences, Inc.IGMS - Longview News-Journal
IGM Biosciences stock plunges to 52-week low of $1.59 By Investing.com - Investing.com Canada
Why Is IGM Biosciences Inc (NASDAQ: IGMS) Falling? - Stocks Register
Igm Biosciences Inc (IGMS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Igm Biosciences Inc 주식 (IGMS) 내부자 거래
내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
---|---|---|---|---|---|---|---|
Weber Steven | PRINCIPAL ACCOUNTING OFFICER |
Dec 16 '24 |
Sale |
7.48 |
539 |
4,032 |
31,704 |
Decker Lisa Lynn | CHIEF BUSINESS OFFICER |
Dec 16 '24 |
Sale |
7.48 |
1,063 |
7,951 |
78,041 |
Harler Mary Beth | Chief Executive Officer |
Dec 16 '24 |
Sale |
7.48 |
1,708 |
12,776 |
347,032 |
Tahir Misbah | CHIEF FINANCIAL OFFICER |
Dec 16 '24 |
Sale |
7.48 |
1,708 |
12,776 |
187,653 |
자본화:
|
볼륨(24시간):